| Fidaxomicin versus Vancomycin for Clostridium difficile Infection TJ Louie, MA Miller, KM Mullane, K Weiss, A Lentnek, Y Golan, S Gorbach, ... New England Journal of Medicine 364 (5), 422-431, 2011 | 1913 | 2011 |
| Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus K Zhang, JA McClure, S Elsayed, T Louie, JM Conly Journal of clinical microbiology 43 (10), 5026-5033, 2005 | 1412 | 2005 |
| Treating Clostridium difficile infection with fecal microbiota transplantation JS Bakken, T Borody, LJ Brandt, JV Brill, DC Demarco, MA Franzos, ... Clinical gastroenterology and hepatology 9 (12), 1044-1049, 2011 | 1272 | 2011 |
| Effect of oral capsule–vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial D Kao, B Roach, M Silva, P Beck, K Rioux, GG Kaplan, HJ Chang, ... Jama 318 (20), 1985-1993, 2017 | 619 | 2017 |
| Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials S Johnson, TJ Louie, DN Gerding, OA Cornely, S Chasan-Taber, D Fitts, ... Clinical Infectious Diseases 59 (3), 345-354, 2014 | 567 | 2014 |
| New Quadriplex PCR Assay for Detection of Methicillin and Mupirocin Resistance and Simultaneous Discrimination of Staphylococcus aureus from Coagulase … K Zhang, J Sparling, BL Chow, S Elsayed, Z Hussain, DL Church, ... Journal of clinical microbiology 42 (11), 4947-4955, 2004 | 561 | 2004 |
| Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from … JA McClure, JM Conly, V Lau, S Elsayed, T Louie, W Hutchins, K Zhang Journal of clinical microbiology 44 (3), 1141-1144, 2006 | 542 | 2006 |
| Microbial synergy in experimental intra-abdominal abscess AB Onderdonk, JG Bartlett, T Louie, N Sullivan-Seigler, SL Gorbach Infection and Immunity 13 (1), 22-26, 1976 | 525 | 1976 |
| Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin OA Cornely, MA Miller, TJ Louie, DW Crook, SL Gorbach Clinical infectious diseases 55 (suppl_2), S154-S161, 2012 | 510 | 2012 |
| A human gut bacterial genome and culture collection for improved metagenomic analyses SC Forster, N Kumar, BO Anonye, A Almeida, E Viciani, MD Stares, ... Nature biotechnology 37 (2), 186-192, 2019 | 488 | 2019 |
| Bacteriology of hospital-acquired pneumonia JG Bartlett, P O'Keefe, FP Tally, TJ Louie, SL Gorbach Archives of internal medicine 146 (5), 868-871, 1986 | 389 | 1986 |
| Handwashing practices in an intensive care unit: the effects of an educational program and its relationship to infection rates JM Conly, S Hill, J Ross, J Lertzman, TJ Louie American Journal of Infection Control 17 (6), 330-339, 1989 | 388 | 1989 |
| Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and … TJ Louie, K Cannon, B Byrne, J Emery, L Ward, M Eyben, W Krulicki Clinical infectious diseases 55 (suppl_2), S132-S142, 2012 | 361 | 2012 |
| Antimicrobial therapy of experimental intraabdominal sepsis WM Weinstein, AB Onderdonk, JG Bartlett, TJ Louie, SL Gorbach Journal of Infectious Diseases 132 (3), 282-286, 1975 | 323 | 1975 |
| Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials DW Crook, AS Walker, Y Kean, K Weiss, OA Cornely, MA Miller, ... Clinical Infectious Diseases 55 (suppl_2), S93-S103, 2012 | 310 | 2012 |
| Aerobic and anaerobic bacteria in diabetic foot ulcers TJ LOUIE, JG BARTLETT, FP TALLY, SL GORBACH Annals of internal medicine 85 (4), 461-463, 1976 | 309 | 1976 |
| Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections KM Mullane, MA Miller, K Weiss, A Lentnek, Y Golan, PS Sears, YK Shue, ... Clinical infectious diseases 53 (5), 440-447, 2011 | 306 | 2011 |
| SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection P Feuerstadt, TJ Louie, B Lashner, EEL Wang, L Diao, JA Bryant, M Sims, ... New England Journal of Medicine 386 (3), 220-229, 2022 | 296 | 2022 |
| Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile–Associated Diarrhea TJ Louie, J Peppe, CK Watt, D Johnson, R Mohammed, G Dow, K Weiss, ... Clinical infectious diseases 43 (4), 411-420, 2006 | 296 | 2006 |
| A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin GW Tannock, K Munro, C Taylor, B Lawley, W Young, B Byrne, J Emery, ... Microbiology 156 (11), 3354-3359, 2010 | 272 | 2010 |
